Timber Pharmaceuticals Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Timber Pharmaceuticals current Real Value cannot be determined due to lack of data. The regular price of Timber Pharmaceuticals is $0.0. Our model measures the value of Timber Pharmaceuticals from inspecting the company fundamentals such as Return On Equity of -3.43, shares owned by institutions of 7.78 %, and Shares Outstanding of 3.43 M as well as reviewing its technical indicators and probability of bankruptcy.
Timber Pharmaceuticals Total Value Analysis
Timber Pharmaceuticals is at this time forecasted to have valuation of (916.94 K) with market capitalization of 1.18 M, debt of 331.15 K, and cash on hands of 11.22 M. The negative valuation of Timber Pharmaceuticals may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Timber Pharmaceuticals fundamentals.Takeover Price | Market Cap | Debt Obligations | Cash |
(916.94 K) | 1.18 M | 331.15 K | 11.22 M |
Timber Pharmaceuticals Investor Information
The company recorded a loss per share of 1.97. Timber Pharmaceuticals last dividend was issued on the 19th of May 2020. The entity had 1:50 split on the 9th of November 2022. Based on the key indicators related to Timber Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Timber Pharmaceuticals is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Timber Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Timber Pharmaceuticals has an asset utilization ratio of 0.81 percent. This connotes that the Company is making $0.008094 for each dollar of assets. An increasing asset utilization means that Timber Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.Timber Pharmaceuticals Ownership Allocation
About 91.11 % of Timber Pharmaceuticals outstanding shares are held by general public with 1.11 (%) owned by insiders and only 7.78 % by institutional holders.Timber Pharmaceuticals Profitability Analysis
The company reported the previous year's revenue of 83.18 K. Net Loss for the year was (19.38 M) with loss before overhead, payroll, taxes, and interest of (5.26 M).Timber Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Timber Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding | 2.1 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Timber Stock
If you are still planning to invest in Timber Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Timber Pharmaceuticals' history and understand the potential risks before investing.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Transaction History View history of all your transactions and understand their impact on performance | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |